Article Text

Download PDFPDF

Development of a screening tool to predict the risk of chronic pain and disability following musculoskeletal trauma: protocol for a prospective observational study in the United Kingdom
  1. Alison B Rushton1,2,
  2. David W Evans1,2,
  3. Nicola Middlebrook1,2,
  4. Nicola R Heneghan1,
  5. Charlotte Small2,
  6. Janet Lord2,
  7. Jaimin M Patel2,
  8. Deborah Falla1,2
  1. 1 Centre of Precision Rehabilitation for SpinalPain (CPR Spine), School of Sport, Exercise and Rehabilitation Sciences, College of Life and Environmental Sciences, University of Birmingham, Birmingham, UK
  2. 2 NIHR Surgical Reconstruction and Microbiology Research Centre, University of Birmingham, Birmingham, UK
  1. Correspondence to Professor Deborah Falla; d.falla{at}bham.ac.uk

Abstract

Introduction Pain is an expected and appropriate experience following traumatic musculoskeletal injury. By contrast, chronic pain and disability are unhelpful yet common sequelae of trauma-related injuries. Presently, the mechanisms that underlie the transition from acute to chronic disabling post-traumatic pain are not fully understood. Such knowledge would facilitate the development and implementation of precision rehabilitation approaches that match interventions to projected risk of recovery, with the aim of preventing poor long-term outcomes. The aim of this study is to identify a set of predictive factors to identify patients at risk of developing ongoing post-traumatic pain and disability following acute musculoskeletal trauma. To achieve this, we will use a unique and comprehensive combination of patient-reported outcome measures, psychophysical testing and biomarkers.

Methods and analysis A prospective observational study will recruit two temporally staggered cohorts (n=250 each cohort; at least 10 cases per candidate predictor) of consecutive patients with acute musculoskeletal trauma aged ≥16 years, who are emergency admissions into a Major Trauma Centre in the United Kingdom, with an episode inception defined as the traumatic event. The first cohort will identify candidate predictors to develop a screening tool to predict development of chronic and disabling pain, and the second will allow evaluation of the predictive performance of the tool (validation). The outcome being predicted is an individual’s absolute risk of poor outcome measured at a 6-month follow-up using the Chronic Pain Grade Scale (poor outcome ≥grade II). Candidate predictors encompass the four primary mechanisms of pain: nociceptive (eg, injury location), neuropathic (eg, painDETECT), inflammatory (biomarkers) and nociplastic (eg, quantitative sensory testing). Concurrently, patient-reported outcome measures will assess general health and psychosocial factors (eg, pain self-efficacy). Risk of poor outcome will be calculated using multiple variable regression analysis.

Ethics and dissemination Approved by the NHS Research Ethics Committee (17/WA/0421).

  • musculoskeletal trauma
  • precision rehabilitation
  • pain mechanisms

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors DF is Chief Investigator and guarantor. DF and ABR led protocol development, data analysis and dissemination. DWE is the Research Fellow with responsibility for study management. NM is a Doctoral Researcher focused to this study. NRH is the lead for patient and public involvement. JMP is the Principal Investigator at the Major Trauma Centre. JMP and CS are clinical representatives at the Major Trauma Centre. JL is the lead for biomarker evaluation. All authors will contribute to data interpretation, conclusions and dissemination. ABR drafted the initial manuscript with DF. Subsequent drafts were developed with DWE. All reviewers have read, contributed to and agreed upon the final manuscript.

  • Funding This work was supported by the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC) to DF and ABR.

  • Competing interests None declared.

  • Patient consent Not required.

  • Ethics approval Approved by the NHS Research Ethics Committee (17/WA/0421).

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement No additional data are available.